G01N2800/7014 - CPC Classification Index

#1

20250288647

2025-09-18

ANGIOGENESIS INHIBITING PEPTIDE AND USE THEREOF

#2

20250198987

2025-06-19

SYSTEM FOR MEASURING METASTATIC POTENTIAL OF CANCER CELLS AND METHOD FOR MEASURING METASTATIC POTENTIAL OF CANCER CELLS BY USING SAME

#3

20220252602

2022-08-11

ARTIFICIAL INTELLIGENCE FOR EARLY CANCER DETECTION

#4

20210405064

2021-12-30

BI-FUNCTIONAL ARGININE-GLYCINE-ASPARTIC ACID (RGD) PEPTIDES AND METHODS TO PROMOTE ANGIOGENESIS

#5

20210323918

2021-10-21

COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING A GROWTH RELATED DISEASE AND/OR A CLINICAL CONDITION THEREOF

#6

20210190759

2021-06-24

Composition for detecting hydrogen sulfide or measuring hydrogen sulfide concentration and composition comprising same as effective ingredient for diagnosing or imaging in vivo inflammation, tissues having hypoxic damage, or cancer

#7

20210055307

2021-02-25

METHOD FOR MONITORING DEVELOPMENT OF THE CENTRAL NERVOUS SYSTEM

#8

20210033611

2021-02-04

Methods and compounds for diagnosing threonyl-tRNA synthetase-associated diseases and conditions

#9

20200041490

2020-02-06

Hypoxic NK cells and methods therefor

#10

20190285653

2019-09-19

Treatment for age-related macular degeneration (AMD) and pathogenic ocular neovascularization

#11

20190162731

2019-05-30

METHOD FOR MONITORING FETUS/PRETERM INFANT DEVELOPMENT, AND FOR PROMOTING THE NORMAL DEVELOPMENT OF PRETERM INFANTS

#12

20190120842

2019-04-25

Methods and compounds for diagnosing threonyl-tRNA synthetase-associated diseases and conditions

#13

20190062722

2019-02-28

Methods and compounds for reducing threonyl-tRNA synthetase activity

#14

20190062425

2019-02-28

TM4SF1 binding proteins and methods of using same

#15

20190048387

2019-02-14

Method and kit for assessing possibility of cancerization

#16

20190033323

2019-01-31

Detection of angiopoietin-2 and thrombospondin-2 in connection with diagnosing acute heart failure

#17

20180362979

2018-12-20

THERAPEUTIC AND DIAGNOSTIC MOLECULES

#18

20180163210

2018-06-14

Compositions and methods for controlling vasculature

#19

20180143199

2018-05-24

METHODS OF IDENTIFYING GLIOBLASTOMA PATIENTS AS SUSCEPTIBLE TO ANTI-ANGIOGENIC THERAPY USING QUANTITATIVE IMAGING FEATURES AND MOLECULAR PROFILING

#20

20180120332

2018-05-03

Bi-functional arginine-glycine-aspartic acid (RGD) peptides and methods to promote angiogenesis

#21

20180110837

2018-04-26

METHODS AND ASSAYS RELATING TO MACROPHAGE DIFFERENTIATION

#22

20180066263

2018-03-08

Nucleic acid aptamers binding to vascular endothelial growth factor receptors

#23

20180051064

2018-02-22

Neuropilin-1 specific binding peptide, fusion protein fused with same, and use thereof

#24

20170328910

2017-11-16

PRO-ANGIOGENIC AND ANTI-ANGIOGENIC HEMATOPOIETIC PROGENITOR CELL POPULATIONS

#25

20170298434

2017-10-19

Methods for measuring and reporting vascularity in a tissue sample

#26

20170182114

2017-06-29

Aurantiamide dipeptide derivatives for treatment or prevention of angiogenesis-related diseases

#27

20160376339

2016-12-29

Decoy peptides inhibiting binding of AMIGO2 and 3-phosphoinositide-dependent kinase 1

#28

20160355807

2016-12-08

THERAPEUTIC AND DIAGNOSTIC MOLECULES

#29

20160229910

2016-08-11

TM4SF1 binding proteins and methods of using same

#30

20160116458

2016-04-28

Cell model for neovascular diseases using EBV-infected human corneal epithelial cells

#31

20160103120

2016-04-14

Construction of mitochondrial UQCRB mutant expressing cells and utilization of the cells for UQCRB assay system thereof

#32

20160084853

2016-03-24

Methods of using VEGF-C biomarkers for age-related macular degeneration (AMD) diagnosis

#33

20160053000

2016-02-25

Methods of treating retinal disorders with anti-apelin antibodies

#34

20160009790

2016-01-14

Anti-Vasohibin 2 antibody

#35

20150253232

2015-09-10

DEVICE FOR INVESTIGATION OF A FLOW CONDUIT

#36

20150210997

2015-07-30

Methods and compounds for reducing threonyl-tRNA synthetase activity

#37

20150177243

2015-06-25

Methods and compounds for diagnosing threonyl-tRNA synthetase-associated diseases and conditions

#38

20150139934

2015-05-21

Methods for screening patients for resistance to angioinhibition, treatment and prophylaxis thereof

#39

20150093373

2015-04-02

Treatment of pulmonary vascular remodeling with neprilysin

#40

20150023973

2015-01-22

Pharmaceutical compositions for preventing or treating angiogenic diseases comprising inhibitors of NUP153 gene expression or NUP153 activity as active ingredient

#41

20150010572

2015-01-08

Ang-2 specific antibodies and uses thereof

#42

20140342924

2014-11-20

Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent

#43

20140328850

2014-11-06

Apelin antigen-binding proteins and uses thereof

#44

20140171488

2014-06-19

Composition for inhibiting angiogenesis containing a peroxidasin inhibitor as an active ingredient

#45

20140037655

2014-02-06

Use of nucleolin as a biomarker for lymphangiogenesis in a cancer prognosis and therapy

#46

20140004040

2014-01-02

Methods and compositions for targeting sites of neovascular growth

#47

20130023479

2013-01-24

USE OF NUCLEOLIN AS A BIOMARKER FOR LYMPHANGIOGENESIS IN CANCER PROGNOSIS AND THERAPY

#48

20120283306

2012-11-08

MOUSE MODEL FOR AVM

#49

20120225063

2012-09-06

TREATMENT RESPONSE TO ANTI-ANGIOGENIC THERAPIES

#50

20120196925

2012-08-02

Therapeutic and diagnostic molecules

#51

20120121573

2012-05-17

Treatment of pulmonary vascular remodeling with neprilysin

#52

20120077734

2012-03-29

Methods and assays for treating conditions in which macrophages play a pathogenic role

#53

20110104124

2011-05-05

Mesodermal-like cell population for treating ischemia in mammals

#54

20110027177

2011-02-03

Inhibition of angiogenesis

#55

20100004168

2010-01-07

Use of Crystallin For The Modulation of Angiogenesis

#56

14588319

2017-08-08

Methods for measuring and reporting vascularity in a tissue sample